March 23, 2022 8:50 am
Covovax is the fourth COVID-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.
February 21, 2022 7:55 pm
The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28.
December 23, 2021 6:02 pm
🔴 Coronavirus infections have soared across much of the world as the highly infectious Omicron variant has spread, triggering new curbs in many countries.
November 27, 2021 8:35 am
The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.
November 05, 2021 9:13 am
The company submitted to the health agency all modules required for the evaluation of NVX-CoV2373, its protein-based Covid-19 vaccine, days after receiving its first emergency use authorization from Indonesia.
September 04, 2021 3:13 pm
This vaccine is the fourth one to undergo clinical trials in children in India.
July 02, 2021 8:44 am
Taiwan's vaccine orders include 4.76 million doses from COVAX, though so far it has only received slightly more than 600,000 from the scheme, all AstraZeneca Plc shots.
June 27, 2021 8:59 am
In its affidavit, the Centre said that based on supply estimates, it estimates 51.6 crore cumulative vaccinations by the end of July.
June 15, 2021 7:05 am
The Maryland-headquartered company said its vaccine had demonstrated 100 per cent protection in late-stage trials against moderate and severe disease caused by SARS-CoV-2 — a boost for the prospects of its Indian version, Covovax.
June 03, 2021 5:04 pm
The Pune-based firm has collaborated with the Gamaleya Research Institute of Epidemiology and Microbiology, Moscow for developing Sputnik V at its Hadapsar facility.




